A detailed history of Schroder Investment Management Group transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Schroder Investment Management Group holds 103,508 shares of TERN stock, worth $600,346. This represents 0.0% of its overall portfolio holdings.

Number of Shares
103,508
Previous 254,684 59.36%
Holding current value
$600,346
Previous $1.73 Million 50.23%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$6.49 - $10.8 $981,132 - $1.63 Million
-151,176 Reduced 59.36%
103,508 $863,000
Q2 2024

Aug 12, 2024

BUY
$4.54 - $8.2 $1.16 Million - $2.09 Million
254,684 New
254,684 $1.73 Million

Others Institutions Holding TERN

About Terns Pharmaceuticals, Inc.


  • Ticker TERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,613,800
  • Market Cap $218M
  • Description
  • Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...
More about TERN
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.